ActX Passes 2024 CAP Inspection With Zero Deficiencies

As a College of American Pathologists (CAP) accredited laboratory, ActX, a leader in precision medicine, has passed its most recent CAP inspection with zero deficiencies. On site laboratory inspections occur every two years using a CAP accreditation checklist to assess compliance with the program's requirements.

"The CAP is pleased to recognize ActX as meeting the high standard set as part of the CAP's Laboratory Accreditation Program," said Richard M. Scanlan, MD, FCAP, chair of the CAP's Council on Accreditation. "ActX joins the thousands of others that are committed to raising the quality of laboratory services nationally and internationally."

"At ActX we strive to maintain a laboratory that meets the rigorous CAP standards for accreditation" said Andrew Ury, Founder and CEO of ActX. "We are proud to achieve zero deficiencies, and will work to keep this rigor going forward to help ensure patient's genetic samples are secured in an ideal environment".

To learn more about the CAP Laboratory Accreditation Programs visit the College of American Pathologists page here.